Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Argyle DA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
BMC Veterinary Research, Vol 8, Iss 1, p 73 (2012)
Abstract Background Using novel small-molecular inhibitors, we explored the feasibility of the class I PI3K/Akt/mTORC1 signaling pathway as a therapeutic target in canine oncology either by using pathway inhibitors alone, in combination or combined w
Externí odkaz:
https://doaj.org/article/e49ac7c94af34debae88c44fb13191cb
Autor:
Gelfand BD; Center for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, 22908, USA.; Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, Virginia, 22908, USA.; Department of Biomedical Engineering, University of Virginia School of Medicine, Charlottesville, Virginia, 22908, USA., Argyle DA; Center for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, 22908, USA.; Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA., Olivieri JJ; Center for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, 22908, USA.; Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA., Ambati J; Center for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, 22908, USA.; Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, Virginia, 22908, USA.; Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA.; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, 22908, USA.
Publikováno v:
MedComm - Future medicine [MedComm Futur Med] 2023 Dec; Vol. 2 (4). Date of Electronic Publication: 2023 Oct 03.